首页 › 基金 › Two Seas Capital LP › INDV
Two Seas Capital LP 对 INDV 的持仓历史
INDIVIOR PHARMACEUTICALS INC · 医疗保健
Two Seas Capital LP 在 Q3 2026 的 13F 申报中披露持有 INDV(INDIVIOR PHARMACEUTICALS INC)3,671,072 股,市值约 US$131.6M,约占其申报组合的 1.71%,在其申报持仓中市值排名第 7 位。 Two Seas Capital LP 最近 13 个申报季度中有 13 个季度披露了 INDV 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR
Two Seas Capital LP 对 INDV 的持仓演变
Two Seas Capital LP 于 Q3 2023 首次披露 INDV 持仓:13,670,312 股(约 US$315.4M)。 在 13 次申报中,Two Seas Capital LP 3 次增持、8 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 3,671,072 股、市值约 US$131.6M,环比增持 191,579 股。。 持仓曾出现大幅变动:Q4 2025 减持约 51% (随后一个季度股价下跌 15%)、Q2 2026 减持约 27% (随后一个季度股价下跌 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 13.67M | $315.37M | 新进 |
| Q4 2023 | 13.81M | $210.89M | 增持 |
| Q1 2024 | 13.25M | $283.84M | 减持 |
| Q2 2024 | 12.63M | $203.60M | 减持 |
| Q3 2024 | 13.03M | $127.04M | 增持 |
| Q4 2024 | 12.46M | $154.85M | 减持 |
| Q1 2025 | 11.37M | $106.51M | 减持 |
| Q2 2025 | 11.41M | $168.15M | 持有 |
| Q3 2025 | 10.50M | $253.26M | 减持 |
| Q4 2025 | 5.11M | $183.32M | 减持 |
| Q1 2026 | 4.75M | $144.67M | 减持 |
| Q2 2026 | 3.48M | $142.76M | 减持 |
| Q3 2026 | 3.67M | $131.61M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 INDV 与 13F 数据
INDV(INDIVIOR PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 INDV,申报仓位最大的包括:OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), Madison Avenue Partners, LP (US$117.9M), MANGROVE PARTNERS IM, LLC (US$109.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 INDV 的基金
- OAKTREE CAPITAL MANAGEMENT LP 6.13M 股 · $251.40M · Q2 2026
- Madison Avenue Partners, LP 2.87M 股 · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M 股 · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M 股 · $67.65M · Q2 2026
- Newtyn Management, LLC 1.31M 股 · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M 股 · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M 股 · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K 股 · $28.13M · Q2 2026
- Divisadero Street Capital Management, LP 601.86K 股 · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K 股 · $24.03M · Q2 2026
- Alta Fundamental Advisers LLC 404.53K 股 · $16.60M · Q2 2026
- PFM Health Sciences, LP 401.21K 股 · $16.46M · Q2 2026
更多关于 Two Seas Capital LP
常见问题
How long has Two Seas Capital LP held INDV?
Two Seas Capital LP has disclosed INDV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Two Seas Capital LP's current position in INDV?
As of Q3 2026, Two Seas Capital LP holds 3.67M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $131.61M, representing 1.71% of its reported portfolio and ranking #7.
Has Two Seas Capital LP been buying or selling INDV?
In the latest 13F filing (Q3 2026), Two Seas Capital LP increased its position in INDV.
Which other funds hold INDV?
Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, Madison Avenue Partners, LP, MANGROVE PARTNERS IM, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.